Surrozen
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
| Company Details | |
|---|---|
| Title | Surrozen |
| Industries | Biotechnology, Emergency Medicine, Health Care |
| Headquarters Regions | San Francisco Bay Area, West Coast, Western US |
| Headquarters Location | South San Francisco, California, United States |
| No Of Employees | 51-100 |
| Operating Status | Active |
Description
Surrozen is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with potential application across multiple disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas and central nervous system.